ALTABAX® is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm² in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes [see Clinical Studies]. Safety in patients younger than 9 months has not been established.
To reduce the development of drug resistant bacteria and maintain the effectiveness of ALTABAX and other antibacterial drugs, ALTABAX should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
DOSAGE AND ADMINISTRATION
A thin layer of ALTABAX should be applied to the affected area (up to 100 cm² in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) twice daily for 5 days. The treated area may be covered with a sterile bandage or gauze dressing if desired [see PATIENT INFORMATION].
Dosage Forms And Strengths
Storage And Handling
ALTABAX is supplied in 15-gram and 30-gram tubes.
NDC 16110-518-15 (15-gram tube)
NDC 16110-518-30 (30-gram tube)
Store at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F).
Manufactured by: GlaxoSmithKline, Barnard Castle, County Durham, DL12 8DT, United Kingdom. Manufactured for: Aqua Pharmaceuticals, an Almirall Company, Exton, PA 19341. Revised: Nov 2015This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/5/2016
Additional Altabax Information
Altabax - User Reviews
Altabax User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.